William J. Sharbaugh has been named chief operating officer, PPD, effective May 31. Mr. Sharbaugh joins the company from Bristol-Myers Squibb, where he most recently served as vice president, global development operations, responsible for strategic direction for clinical operations in 55 countries. In this position he provided operational leadership for global clinical operations, data management, patient recruitment and retention, contracting and outsourcing management, clinical supply operations, training and quality management. Prior to BMS, he spent 10 years at Merck & Co. in a variety of assignments in clinical supply operations, sales and manufacturing.
   
“Bill Sharbaugh brings extensive leadership experience and skills as well as a vision that complements and aligns well with the strategic direction we have charted for PPD,” said Fred Eshelman, chief executive officer of PPD. “We are pleased to welcome him to our organization and look forward to his leadership and contributions to our growing business.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters